Immediate Impact
1 by Nobel laureates 3 from Science/Nature 57 standout
Citing Papers
The evolving role of investigative toxicology in the pharmaceutical industry
2023 Standout
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Works of Peng Lü being referenced
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
2013
In silico and in vitro pharmacogenetic analysis in mice
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peng Lü | 152 | 248 | 23 | 134 | 33 | 642 | |
| Zahra Rezaieyazdi | 83 | 207 | 43 | 181 | 56 | 724 | |
| Chantal Lefebvre | 32 | 314 | 53 | 242 | 32 | 656 | |
| Bo Young Yoon | 60 | 245 | 67 | 90 | 45 | 574 | |
| Howard M. Rawnsley | 65 | 101 | 35 | 59 | 21 | 546 | |
| Li Wang | 24 | 169 | 98 | 119 | 44 | 714 | |
| Emmanuel Bissé | 84 | 105 | 86 | 94 | 30 | 648 | |
| T Matsushima | 50 | 54 | 26 | 56 | 16 | 540 | |
| B Olhagen | 36 | 206 | 82 | 75 | 53 | 715 | |
| Herbert C. Lichtman | 248 | 79 | 24 | 47 | 39 | 736 | |
| Zahra Mirfeizi | 21 | 233 | 73 | 81 | 54 | 549 |
All Works
Login with ORCID to disown or claim papers
Loading papers...